Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:36 pm Purchase |
2022-12-31 | 13G | Ibere Pharmaceuticals IBER |
Glazer Capital, LLC | 1,331,102 9.650% |
1,331,102 (New Position) |
Filing History |
| 2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Ibere Pharmaceuticals IBER |
Citadel Advisors LLC | 4,057 0.000% |
-775,377 (-99.48%) |
Filing History |
| 2023-02-08 3:19 pm Purchase |
2022-12-31 | 13G | Ibere Pharmaceuticals IBER |
Hudson Bay Capital Management LP | 716,613 5.190% |
716,613 (New Position) |
Filing History |
| 2023-02-08 2:09 pm Sale |
2022-12-31 | 13G | IBERE PHARMACEUTICALS UNIT 1 C IBERU |
Hartree Partners, LP | 0 0.000% |
-1,285,000 (Position Closed) |
Filing History |
| 2023-02-02 11:10 am Sale |
2022-12-31 | 13G | Ibere Pharmaceuticals IBER |
Magnetar Financial LLC | 785,872 5.690% |
-7,419 (-0.94%) |
Filing History |
| 2022-02-14 06:12 am Purchase |
2021-12-31 | 13G | Ibere Pharmaceuticals IBER |
Citadel Advisors LLC | 779,434 5.600% |
779,434 (New Position) |
Filing History |
| 2022-02-08 4:23 pm Purchase |
2021-12-31 | 13G | Ibere Pharmaceuticals IBER |
PIPV Capital LLC | 3,450,000 20.000% |
3,450,000 (New Position) |
Filing History |
| 2022-01-14 1:43 pm Purchase |
2021-12-31 | 13G | Ibere Pharmaceuticals IBER |
Magnetar Financial LLC | 793,291 5.750% |
793,291 (New Position) |
Filing History |
| 2021-09-27 2:36 pm Purchase |
2021-02-26 | 13G | IBERE PHARMACEUTICALS UNIT 1 C IBERU |
Hartree Partners, LP | 1,285,000 9.300% |
1,285,000 (New Position) |
Filing History |
| 2021-03-12 4:02 pm Purchase |
2021-03-02 | 13G | IBERE PHARMACEUTICALS UNIT 1 C IBERU |
Citadel Advisors LLC | 776,710 5.600% |
776,710 (New Position) |
Filing History |